Edition:
United Kingdom

Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

43.97USD
20 Aug 2019
Change (% chg)

$0.49 (+1.13%)
Prev Close
$43.48
Open
$44.08
Day's High
$44.12
Day's Low
$43.81
Volume
65,865
Avg. Vol
772,140
52-wk High
$58.31
52-wk Low
$41.03

Latest Key Developments (Source: Significant Developments)

Cardinal Health Inc Says On August 7, Appointed David Evans As Interim Chief Financial Officer Of Company, Effective September 1, 2019
Thursday, 8 Aug 2019 

Aug 8 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH INC - ON AUGUST 7, APPOINTED DAVID EVANS AS INTERIM CHIEF FINANCIAL OFFICER OF COMPANY, EFFECTIVE SEPTEMBER 1, 2019.CARDINAL HEALTH INC - MICHAEL KAUFMANN WILL CEASE TO BE INTERIM CHIEF FINANCIAL OFFICER ON SEPTEMBER 1, 2019..CARDINAL HEALTH INC - KAUFMANN WILL CONTINUE TO SERVE AS CHIEF EXECUTIVE OFFICER.  Full Article

Cardinal Health Q4 NON-GAAP Earnings Per Share $1.11
Thursday, 8 Aug 2019 

Aug 8 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH REPORTS FOURTH QUARTER AND FULL YEAR RESULTS FOR FISCAL YEAR 2019.Q4 NON-GAAP EARNINGS PER SHARE $1.11.Q4 GAAP EARNINGS PER SHARE $0.65.Q4 REVENUE $37.4 BILLION VERSUS REFINITIV IBES ESTIMATE OF $36.87 BILLION.Q4 EARNINGS PER SHARE ESTIMATE $0.93 -- REFINITIV IBES DATA.SEES FY 2020 NON-GAAP EARNINGS PER SHARE $4.85 TO $5.10.FY2020 EARNINGS PER SHARE VIEW $5.10 -- REFINITIV IBES DATA.GUIDANCE FOR FISCAL 2020 INCLUDES AN ANTICIPATED INCREMENTAL $130 MILLION IN COST SAVINGS.Q4 REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 6 PERCENT TO $33.4 BILLION.CARDINAL HEALTH - TO RECORD RESTRUCTURING CHARGES IN RANGE OF $120 MILLION TO $145 MILLION, MAJORITY OF WHICH ARE EXPECTED TO BE EXPENSED IN FISCAL YEAR 2020.CARDINAL HEALTH HAS TARGETED ACHIEVING MORE THAN $500 MILLION IN SAVINGS WITHIN FIVE YEARS.CARDINAL HEALTH - EXPECTS TO RECORD RESTRUCTURING CHARGES IN RANGE OF $120 MILLION-$145 MILLION, MAJORITY OF WHICH ARE EXPECTED TO BE IN FISCAL YEAR 2020.FY 2020 GUIDANCE RANGE FOR NON-GAAP DILUTED EARNINGS PER SHARE ATTRIBUTABLE TO CARDINAL HEALTH, INC. IS $4.85 TO $5.10.  Full Article

McKesson, Cardinal, Amerisourcebergen Propose Paying $10 Bln To Settle Claims They Helped Fuel Opioid Epidemic - Bloomberg
Tuesday, 6 Aug 2019 

Aug 6 (Reuters) - :DRUG DISTRIBUTORS MCKESSON, CARDINAL, AMERISOURCEBERGEN PROPOSE PAYING $10 BILLION TO SETTLE CLAIMS THEY HELPED FUEL OPIOID EPIDEMIC - BLOOMBERG REPORTER TWEET.  Full Article

Cardinal Health Says Jorge Gomez, CFO, Has Notified Co That He Will Leave Co Effective August 9
Monday, 8 Jul 2019 

July 8 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH INC - JORGE M. GOMEZ, CFO, HAS NOTIFIED CO THAT HE WILL LEAVE CO EFFECTIVE AUGUST 9, 2019 - SEC FILING.CARDINAL HEALTH INC - CEO MICHAEL C. KAUFMANN, 56, WILL ASSUME ADDITIONAL ROLE OF INTERIM CFO EFFECTIVE AUGUST 9.  Full Article

Cardinal Health Sees FY Revenue With Mid-Single Digit Percentage Growth
Thursday, 9 May 2019 

May 9 (Reuters) - Cardinal Health Inc ::SEES FY REVENUE WITH MID-SINGLE DIGIT PERCENTAGE GROWTH.SEES HIGH-SINGLE TO LOW-DOUBLE DIGIT PERCENTAGE DECLINE IN PROFIT FOR PHARMACEUTICAL SEGMENT IN FY.SEES MID TO HIGH-SINGLE DIGIT PERCENTAGE GROWTH IN REVENUE FOR PHARMACEUTICAL SEGMENT IN FY.SEES FY19 MEDICAL SEGMENT PROFIT LOW TO MID-SINGLE DIGIT PERCENTAGE DECLINE.FY2019 REVENUE VIEW $145.18 BILLION -- REFINITIV IBES DATA.  Full Article

Cardinal Health Reports Q3 Results
Thursday, 9 May 2019 

May 9 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH REPORTS THIRD QUARTER RESULTS FOR FISCAL YEAR 2019.Q3 NON-GAAP EARNINGS PER SHARE $1.59.Q3 GAAP EARNINGS PER SHARE $0.99.Q3 REVENUE $35.2 BILLION VERSUS REFINITIV IBES ESTIMATE OF $35.2 BILLION.Q3 EARNINGS PER SHARE ESTIMATE $1.43 -- REFINITIV IBES DATA.RAISES FY 2019 NON-GAAP EARNINGS PER SHARE VIEW TO $5.02 TO $5.17.COMPANY RAISES LOWER END OF FY19 GUIDANCE.COMPANY EXTENDED DISTRIBUTION AGREEMENTS WITH CVS HEALTH THROUGH JUNE 30, 2023.FY2019 EARNINGS PER SHARE VIEW $5.08 -- REFINITIV IBES DATA.Q3 REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 6 PERCENT TO $31.4 BILLION.CARDINAL HEALTH - Q3 REVENUE FOR MEDICAL SEGMENT WAS DOWN 1 PERCENT DUE TO DIVESTITURES OF CHINA DISTRIBUTION AND NAVIHEALTH BUSINESSES.SEES 2019 CAPITAL EXPENDITURES $310 MILLION - $340 MILLION.  Full Article

Cardinal Health Sees FY 2019 Revenue Of Low-Single Digit Percentage Growth
Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH SEES FY 2019 REVENUE OF LOW-SINGLE DIGIT PERCENTAGE GROWTH.CARDINAL HEALTH SEES FY 2019 CAPITAL EXPENDITURES $360 MILLION - $390 MILLION.CARDINAL HEALTH SEES FY 2019 PHARMACEUTICAL REVENUE OF LOW-SINGLE DIGIT PERCENTAGE GROWTH.CARDINAL HEALTH SEES FY 2019 PHARMACEUTICAL PROFIT OF HIGH-SINGLE TO LOW-DOUBLE DIGIT PERCENTAGE DECLINE.  Full Article

Cardinal Health Reports Q3 Non-GAAP Earnings Per Share $1.39
Thursday, 3 May 2018 

May 3 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH REPORTS THIRD-QUARTER RESULTS FOR FISCAL YEAR 2018.Q3 NON-GAAP EARNINGS PER SHARE $1.39.Q3 GAAP EARNINGS PER SHARE $0.81.Q3 REVENUE $33.6 BILLION VERSUS I/B/E/S VIEW $33.45 BILLION.Q3 EARNINGS PER SHARE VIEW $1.51 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $4.85 TO $4.95.UPDATES FISCAL YEAR 2018 OUTLOOK..THIRD-QUARTER REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 5 PERCENT TO $29.7 BILLION.  Full Article

Cordis And Medinol Announce FDA Approval Of EluNIR Drug-Eluting Stent System
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Cardinal Health Inc ::CORDIS AND MEDINOL ANNOUNCE FDA APPROVAL OF THE INNOVATIVE ELUNIR DRUG-ELUTING STENT SYSTEM.  Full Article

Shanghai Pharmaceuticals' unit‍ signs deal to acquire Cardinal in Malaysia
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says its unit‍ Century Global signs deal to acquire Cardinal Malaysia for about $557 million.  Full Article

UPDATE 1-U.S. judge expresses support for novel opioid settlement talks framework

Aug 6 A federal judge on Tuesday expressed support for a novel plan by lawyers representing cities and counties suing drug companies over the U.S. opioid epidemic that would bring every community nationally into their settlement talks despite objections from most states.